MPN Research Foundation and Canadian MPN Research Foundation are pleased to announce a new collaboration focused on improving outcomes for myeloproliferative neoplasm (MPN) patients in the U.S., Canada, and beyond. The goal of the strategic initiative is to combine expertise and resources and work together to fund and support research leading to new and better treatments and possible cures for these diseases.
MPN Research Foundation and CMPNRF are confident that together the two organizations can enhance their positive impact on the lives of patients and their families by combining funding activities and working together on key research-related projects. At the same time, each foundation will maintain and foster its unique connection with patients and researchers in its home country. “Our proposed alliance will allow both organizations’ country-specific initiatives to thrive, while eliminating duplication of effort and maximizing efficient use of resources on important joint projects,” stated Kapila Viges, Chief Executive Officer of MPN Research Foundation.
Merrill Pierce, Chair of the CMPNRF Board, added, “United, we are more empowered to drive innovation and break new ground in MPN research, bringing us closer to a future without these diseases”.
MPNRF currently funds researchers worldwide and is actively developing relationships with patient groups outside of the United States. Under the collaboration, CMPNRF would join in these funding efforts, while retaining the ability to separately fund Canadian-based research.
“MPNRF and CMPNRF are proud and excited to embark on this partnership, and hope it is the first step of many more in bringing worldwide attention to MPNs”, noted Barbara Vanhusen, Chair of the MPNRF Board. “Together, we are committed to accelerating MPN research and making a lasting difference for patients around the globe.”
About the Organizations
MPN Research Foundation was founded in 1999 by a group of MPN patients determined to stimulate original research into the MPNs, an often misunderstood and underdiagnosed set of blood cancers that involve overproduction of blood cells in the bone marrow. CMPNRF was founded in 2018 to pursue the same mission, with a focus on patients and researchers in Canada.
Information on the two foundations can be found at www.mpnrf.org and www.cmpnrf.ca.